The Innovation Awards fund high-priority research to improve radiopharmaceutical therapy (RPT) outcomes. Projects may explore diverse targets, agents, and radioisotopes to advance RPT as a broadly applicable treatment. Awards provide up to $150,000 over two years to qualified radiation oncology researchers in US and Canada institutions.
Eligible applicants are qualified individuals in radiation oncology excluding pre-doctoral students. Residents and post-docs need a faculty mentor. The host institution must be a qualified 501(c)(3) or government-sponsored university in the US or Canada.
